Corvus Pharmaceuticals, Inc. (CRVS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 1.5300 |
| Open | 1.5200 |
| Bid | 0.0000 x 1100 |
| Ask | 1.6200 x 900 |
| Day's range | 1.4700 - 1.6300 |
| 52-week range | 0.6070 - 4.1900 |
| Volume | |
| Avg. volume | 245,307 |
| Market cap | 78.952M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6400 |
| Earnings date | 07 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.88 |
ZacksIs Corvus Pharmaceuticals (CRVS) Stock Outpacing Its Medical Peers This Year?
Here is how Corvus Pharmaceuticals (CRVS) and Journey Medical Corporation (DERM) have performed compared to their sector so far this year.
Insider MonkeyCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript November 7, 2023 Corvus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.16. Operator: Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2023 Business Update and Financial Results Conference Call. At this time, […]
- Thomson Reuters StreetEvents
Q3 2023 Corvus Pharmaceuticals Inc Earnings Call
Q3 2023 Corvus Pharmaceuticals Inc Earnings Call
© 2023 Yahoo. All rights reserved.